Growth Metrics

Resmed (RMD) Net Margin (2016 - 2025)

Resmed's Net Margin history spans 17 years, with the latest figure at 27.59% for Q4 2025.

  • For Q4 2025, Net Margin rose 71.0% year-over-year to 27.59%; the TTM value through Dec 2025 reached 27.53%, up 218.0%, while the annual FY2025 figure was 27.22%, 543.0% up from the prior year.
  • Net Margin reached 27.59% in Q4 2025 per RMD's latest filing, up from 26.1% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 28.26% in Q1 2025 to a low of 10.21% in Q1 2021.
  • Average Net Margin over 5 years is 21.68%, with a median of 22.4% recorded in 2021.
  • Peak YoY movement for Net Margin: crashed -3141bps in 2021, then surged 3092bps in 2022.
  • A 5-year view of Net Margin shows it stood at 22.55% in 2021, then dropped by -3bps to 21.76% in 2022, then fell by -17bps to 17.96% in 2023, then surged by 50bps to 26.88% in 2024, then rose by 3bps to 27.59% in 2025.
  • Per Business Quant, the three most recent readings for RMD's Net Margin are 27.59% (Q4 2025), 26.1% (Q3 2025), and 28.17% (Q2 2025).